Additionally, assessing GSTP1 methylation could provide prognostic information, as some studies have suggested a correlation between hypermethylation and poor clinical outcomes, including advanced tumor stage, higher recurrence rates, and reduced overall survival. This evidence concerns the gene GSTP1 and neoplasm.